Thus, SLE-IC engage activating FcγRs to promote neutrophil to nAPC conversion in the absence of GM-CSF and TLR signaling and, notably, engagement of either human FcγRIIA or FcγRIIIB triggers this conversion. The gene discussed is CSF2; the disease is systemic lupus erythematosus.